On October 28, Huadong Medicine Co.,Ltd. (000963) issued an announcement stating that the company convened the eighth meeting of its eleventh board of directors on October 28, 2026.
During the meeting, the board reviewed and approved the proposal regarding the company's 2026 Third Quarter Report.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments